Tabula Rasa and Hesperos Receive $1.9M National Institutes of Health Award for Research Focused on Preventable Drug-Induced Alzheimer's Disease

[In The News]

MOORESTOWN, N.J., Aug. 25, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, and Hesperos Inc., pioneers of Human-on-a-Chip® in vitro systems, have been awarded $1.9 million in funding...

View the full article